Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

University of Toronto

$248,463.00

A novel 3D tissue-engineered platform to identify novel therapy targets in head and neck squamous cell carcinoma.

EF 2015-16

Résumé
Survival rates for many cancer types are poor and there is a need for new therapies to be developed. A major challenge is identifying the most promising drugs that will be effective in patients. Currently new drugs are tested on cells cultured in 2D plastic dishes. Studies using this approach however, do not accurately predict how well the drug will work in patients. One reason contributing to the poor predictability of 2D dishes is that the environment is very different from that in a real tumor in a patient and cell properties (and how they respond to a drug) are strongly dependent on their local environment. A need exists for models that better recapitulate the tumor environment and allow an accurate assessment of new drugs to ensure the most promising therapies reach patients faster. We have developed a strategy to engineer artificial tumours in which such analysis is possible. Here we will assess the benefits of our new approach compared to standard 2D dishes and compared to animal models and then use our platform to test the effectiveness of new drugs to treat head and neck cancer.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
346249
Name
McGuigan Alison P
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
A novel 3D tissue-engineered platform to identify novel therapy targets in head and neck squamous cell carcinoma.
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$248,463
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Co-Culture; Head And Neck Squamous Cell Carcinoma; Hypoxia; In Vitro Drug Screening; Metabolomics; Stroma; Therapy Resistance; Tissue Engineering; Tumour Microenvironment
Abstract
Survival rates for many cancer types are poor and there is a need for new therapies to be developed. A major challenge is identifying the most promising drugs that will be effective in patients. Currently new drugs are tested on cells cultured in 2D plastic dishes. Studies using this approach however, do not accurately predict how well the drug will work in patients. One reason contributing to the poor predictability of 2D dishes is that the environment is very different from that in a real tumor in a patient and cell properties (and how they respond to a drug) are strongly dependent on their local environment. A need exists for models that better recapitulate the tumor environment and allow an accurate assessment of new drugs to ensure the most promising therapies reach patients faster. We have developed a strategy to engineer artificial tumours in which such analysis is possible. Here we will assess the benefits of our new approach compared to standard 2D dishes and compared to animal models and then use our platform to test the effectiveness of new drugs to treat head and neck cancer.
Competitiondate
201603
Approvedterm2
3 yrs 0 mth
Pinamesdelim
McGuigan, Alison P
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $248,463~ $0~